IL176223A0 - The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same - Google Patents
The glucagon-like peptide-1 receptor agonists, the preparation and the use of the sameInfo
- Publication number
- IL176223A0 IL176223A0 IL176223A IL17622306A IL176223A0 IL 176223 A0 IL176223 A0 IL 176223A0 IL 176223 A IL176223 A IL 176223A IL 17622306 A IL17622306 A IL 17622306A IL 176223 A0 IL176223 A0 IL 176223A0
- Authority
- IL
- Israel
- Prior art keywords
- glucagon
- peptide
- preparation
- same
- receptor agonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101093310A CN100453533C (en) | 2003-12-12 | 2003-12-12 | Acceptor excitant of a class of pancreas hyperglycemia peptide-1, preparation method and usage |
| PCT/CN2003/001115 WO2005056537A1 (en) | 2003-12-12 | 2003-12-25 | The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL176223A0 true IL176223A0 (en) | 2006-10-05 |
Family
ID=34661371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL176223A IL176223A0 (en) | 2003-12-12 | 2006-06-08 | The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7838682B2 (en) |
| EP (1) | EP1695968A4 (en) |
| JP (1) | JP4527665B2 (en) |
| KR (1) | KR100764863B1 (en) |
| CN (1) | CN100453533C (en) |
| AU (1) | AU2003296205B2 (en) |
| BR (1) | BR0318631A (en) |
| CA (1) | CA2549355A1 (en) |
| IL (1) | IL176223A0 (en) |
| RU (1) | RU2342368C2 (en) |
| UA (1) | UA87122C2 (en) |
| WO (1) | WO2005056537A1 (en) |
| ZA (1) | ZA200605721B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1884278A (en) * | 2005-06-24 | 2006-12-27 | 中国科学院上海药物研究所 | Glucagon-like peptide-1 receptor regulator, its preparation method and uses |
| CN1896069B (en) * | 2005-07-15 | 2011-10-05 | 中国科学院上海药物研究所 | Substituted-thiazole-4-ketone, its preparation and use |
| CN101195613B (en) * | 2006-12-05 | 2012-08-08 | 中国科学院上海药物研究所 | Compound with substituted tetratomic ring structure and medicine use thereof |
| CN101195585A (en) * | 2006-12-05 | 2008-06-11 | 中国科学院上海药物研究所 | Compound with substituted cyclohexane structure, production method and medicine use thereof |
| CN101195612B (en) * | 2006-12-05 | 2012-08-08 | 中国科学院上海药物研究所 | Compound with substituted cyclobutane structure, production method and medicine use thereof |
| CN101195584A (en) * | 2006-12-05 | 2008-06-11 | 中国科学院上海药物研究所 | Compound with substituted cyclopropane structure, production method and medicine use thereof |
| CN101195586A (en) * | 2006-12-05 | 2008-06-11 | 中国科学院上海药物研究所 | Compound with substituted cyclopentane structure, production method and medicine use thereof |
| CN101274927B (en) * | 2007-03-29 | 2011-04-27 | 中国科学院上海药物研究所 | Photochemical reaction preparation for quaternary ring compound and use of the quaternary ring compound |
| WO2011048614A2 (en) | 2009-10-22 | 2011-04-28 | Cadila Healthcare Limited | Short chain peptidomimetics based orally active glp-1 agonist and glucagon receptor antagonist |
| EP2668951B9 (en) | 2011-01-25 | 2017-03-15 | Viviabiotech, S.L. | 1,2,4-oxadiazole derivatives as drugs modulating the glp-1 peptide receptor |
| US9409006B2 (en) | 2011-04-10 | 2016-08-09 | David Hirshberg | Fat removal device and obesity treatment |
| WO2020204602A1 (en) * | 2019-04-02 | 2020-10-08 | 연세대학교 산학협력단 | Novel compound and composition for prevention or treatment of respiratory diseases comprising same as active ingredient |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5811950B2 (en) * | 1976-12-25 | 1983-03-05 | 味の素株式会社 | Process for producing 2,4-substituted-5-oxazolone |
| US4912221A (en) * | 1988-10-27 | 1990-03-27 | Occidental Chemical Corporation | Chiral 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and precursors and preparation thereof |
| JPH0350532A (en) * | 1989-07-19 | 1991-03-05 | Ajinomoto Co Inc | Organic nonlinear optical material |
| JPH09244229A (en) * | 1996-03-07 | 1997-09-19 | Toshiba Corp | Photosensitive composition and pattern forming method using same |
| JP3050532B2 (en) * | 1997-04-02 | 2000-06-12 | 山進工業株式会社 | roll |
| JP3092583B2 (en) * | 1998-03-23 | 2000-09-25 | 日本電気株式会社 | Organic electroluminescent device material and organic electroluminescent device using the same |
| AR037714A1 (en) * | 2001-12-06 | 2004-12-01 | Maxia Pharmaceuticals Inc | DERIVATIVES OF TIAZOLIDINONA AND OXAZOLIDINONA 2-SUBSTITUTED FOR THE INHIBITION OF PHOSPHATES AND THE TREATMENT OF CANCER |
-
2003
- 2003-12-12 CN CNB2003101093310A patent/CN100453533C/en not_active Expired - Fee Related
- 2003-12-25 US US10/582,580 patent/US7838682B2/en not_active Expired - Fee Related
- 2003-12-25 JP JP2005511631A patent/JP4527665B2/en not_active Expired - Fee Related
- 2003-12-25 KR KR1020067013965A patent/KR100764863B1/en not_active IP Right Cessation
- 2003-12-25 UA UAA200607009A patent/UA87122C2/en unknown
- 2003-12-25 BR BRPI0318631-8A patent/BR0318631A/en not_active IP Right Cessation
- 2003-12-25 WO PCT/CN2003/001115 patent/WO2005056537A1/en active Application Filing
- 2003-12-25 RU RU2006124796/04A patent/RU2342368C2/en not_active IP Right Cessation
- 2003-12-25 EP EP03785463A patent/EP1695968A4/en not_active Withdrawn
- 2003-12-25 AU AU2003296205A patent/AU2003296205B2/en not_active Ceased
- 2003-12-25 CA CA002549355A patent/CA2549355A1/en not_active Abandoned
-
2006
- 2006-06-08 IL IL176223A patent/IL176223A0/en unknown
- 2006-07-11 ZA ZA200605721A patent/ZA200605721B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1695968A4 (en) | 2007-08-22 |
| RU2006124796A (en) | 2008-01-27 |
| US20070043093A1 (en) | 2007-02-22 |
| CN1626521A (en) | 2005-06-15 |
| CN100453533C (en) | 2009-01-21 |
| BR0318631A (en) | 2006-10-31 |
| KR20060097065A (en) | 2006-09-13 |
| ZA200605721B (en) | 2007-04-25 |
| EP1695968A1 (en) | 2006-08-30 |
| JP4527665B2 (en) | 2010-08-18 |
| AU2003296205B2 (en) | 2008-09-25 |
| RU2342368C2 (en) | 2008-12-27 |
| CA2549355A1 (en) | 2005-06-23 |
| WO2005056537A1 (en) | 2005-06-23 |
| KR100764863B1 (en) | 2007-10-09 |
| AU2003296205A1 (en) | 2005-06-29 |
| US7838682B2 (en) | 2010-11-23 |
| UA87122C2 (en) | 2009-06-25 |
| JP2007523828A (en) | 2007-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL176223A0 (en) | The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same | |
| AU2003273300A8 (en) | Modified glp-1 receptor agonists and their pharmacological methods of use | |
| IL183940A0 (en) | Glp-1 agonists, compositions, methods and uses | |
| ZA200409333B (en) | 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2B and alpha-2C adrenergic receptors. | |
| AU2002366384A8 (en) | Insulin and igf-1 receptor agonists and antagonists | |
| IL177513A0 (en) | Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof | |
| EP1883419A4 (en) | Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use | |
| ZA200709266B (en) | Human GLP-1 mimetibodies, compositions, methods and uses | |
| HK1079518A1 (en) | Quinazolinone derivatives and their use as cb agonists | |
| EP1541585A4 (en) | Cxcr4 antagonist and use thereof | |
| AU2003236205A1 (en) | Glucagon antagonists/inverse agonists | |
| AU2003238597A8 (en) | Benzimidazole compounds and their use as estrogen agonists/antagonists | |
| HK1078095A1 (en) | Corticotropin releasing factor receptor 2 agonists | |
| PL378244A1 (en) | Pyrrolyl-thiazoles and their use as cb 1 receptor inverse agonists | |
| IL187972A0 (en) | Piperazine-pipridine antagonists and agonists of the 5-ht1a receptor | |
| ZA200210316B (en) | Composition and its therapeutic use. | |
| PL370221A1 (en) | 2-oxazolamines and their use as 5-ht2b receptor antagonists | |
| AU2003210062A1 (en) | Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof | |
| GB0305089D0 (en) | Composition, use and process | |
| AU2003300122A1 (en) | Agonists and antagonists of the human odorant receptor or17-4 and uses thereof | |
| GB2420345B (en) | 3-alpha-glycosyl alpha, alpha-trehaloses their preparation and use | |
| ZA200404994B (en) | Corticotropin releasing factor 2 receptor agonists | |
| IL174101A0 (en) | UBP8rp POLYPEPTIDES, THEIR PREPARATION AND THEIR USE | |
| SI1465923T1 (en) | Corticotropin releasing factor receptor 2 agonists | |
| GB0211926D0 (en) | Polypeptide agonists and antagonists |